AFC-HD AMS Life Science Co logo

2927 - AFC-HD AMS Life Science Co Share Price

¥687 -2.0  -0.3%

Last Trade - 10/07/20

Sector
Consumer Defensives
Size
Small Cap
Market Cap £71.5m
Enterprise Value £68.7m
Revenue £117.0m
Position in Universe 2384th / 3868
Bullish
Bearish
Unlock 2927 Revenue
Momentum
Relative Strength (%)
1m +3.29%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.10%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Aug 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
13,728 14,415 14,631 15,142 15,796 16,253 +3.4%
-46.3 +95.5 -12.0 +47.7 -9.3 -10.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 29 February 2020, AFC-HD AMS Life Science Co Ltd revenues decreased 5% to Y7.89B. Net income decreased 30% to Y352.8M. Revenues reflect Health Care Business segment decrease of 6% to Y7.21B. Net income also reflects Eliminations and Corporate segment loss increase of 43% to Y287.1M. Dividend per share remained flat at Y10.00. Basic Earnings per Share excluding Extraordinary Items decreased from Y35.72 to Y25.09.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

2927 Revenue Unlock 2927 Revenue

Net Income

2927 Net Income Unlock 2927 Revenue

Normalised EPS

2927 Normalised EPS Unlock 2927 Revenue

PE Ratio Range

2927 PE Ratio Range Unlock 2927 Revenue

Dividend Yield Range

2927 Dividend Yield Range Unlock 2927 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
2927 EPS Forecasts Unlock 2927 Revenue
Profile Summary

AFC-HD AMS Life Science Co., Ltd. is Japan-based company mainly engaged in the development, manufacture and sale of healthcare food and pharmaceuticals. The Company operates in two business segments. The Healthcare segment is engaged in the original equipment manufacturing (OEM), manufacture and sales of health food and cosmetics. The Medicine segment is engaged in the manufacture and sale of medicines for ophthalmic medicine and over-the-counter (OTC) drugs, as well as sales of generic drugs.

Directors
Last Annual August 31st, 2019
Last Interim February 29th, 2020
Incorporated December 8, 1980
Public Since March 3, 2005
No. of Shareholders: 10,997
No. of Employees: 589
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange Tokyo Stock Exchange
Shares in Issue 14,063,708
Free Float (0.0%)
Eligible for
ISAs
SIPPs
2927 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 2927
Upcoming Events for 2927
Friday 28th August, 2020
Dividend For 2927.T - 10.0000 JPY
Frequently Asked Questions for AFC-HD AMS Life Science Co
What is the AFC-HD AMS Life Science Co share price?

As of 10/07/20, shares in AFC-HD AMS Life Science Co are trading at ¥687, giving the company a market capitalisation of £71.5m. This share price information is delayed by 15 minutes.

How has the AFC-HD AMS Life Science Co share price performed this year?

Shares in AFC-HD AMS Life Science Co are currently trading at ¥687 and the price has moved by 1.93% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AFC-HD AMS Life Science Co price has moved by -1.03% over the past year.

What are the analyst and broker recommendations for AFC-HD AMS Life Science Co?

Of the analysts with advisory recommendations for AFC-HD AMS Life Science Co, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for AFC-HD AMS Life Science Co is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will AFC-HD AMS Life Science Co next release its financial results?

AFC-HD AMS Life Science Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-01
What is the AFC-HD AMS Life Science Co dividend yield?

The AFC-HD AMS Life Science Co dividend yield is 2.91% based on the trailing twelve month period.

Does AFC-HD AMS Life Science Co pay a dividend?

Last year, AFC-HD AMS Life Science Co paid a total dividend of 20, and it currently has a trailing dividend yield of 2.91%. Looking ahead, shares in AFC-HD AMS Life Science Co are due to go ex-dividend on 2020-08-28 and the next dividend pay date is 2020-11-01.

When does AFC-HD AMS Life Science Co next pay dividends?

AFC-HD AMS Life Science Co are due to go ex-dividend on 2020-08-28 and the next dividend pay date is 2020-11-01. The historic dividend yield on AFC-HD AMS Life Science Co shares is currently 2.91%.

How do I buy AFC-HD AMS Life Science Co shares?

To buy shares in AFC-HD AMS Life Science Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AFC-HD AMS Life Science Co?

Shares in AFC-HD AMS Life Science Co are currently trading at ¥687, giving the company a market capitalisation of £71.5m.

Where are AFC-HD AMS Life Science Co shares listed? Where are AFC-HD AMS Life Science Co shares listed?

Here are the trading details for AFC-HD AMS Life Science Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 2927
What kind of share is AFC-HD AMS Life Science Co?

Based on an overall assessment of its quality, value and momentum, AFC-HD AMS Life Science Co is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a AFC-HD AMS Life Science Co share price forecast 2020?

We were not able to load any forecast data for AFC-HD AMS Life Science Co.

How can I tell whether the AFC-HD AMS Life Science Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AFC-HD AMS Life Science Co. Over the past six months, the relative strength of its shares against the market has been 9.37%. At the current price of ¥687, shares in AFC-HD AMS Life Science Co are trading at 5.4% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AFC-HD AMS Life Science Co PE Ratio?

The AFC-HD AMS Life Science Co PE ratio based on its reported earnings over the past 12 months is 14.71. The shares are currently trading at ¥687.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of AFC-HD AMS Life Science Co?

AFC-HD AMS Life Science Co's management team is headed by:

Takehiko Asayama - PRE
Shigenori Fukuchi - MDR
Hiroyuki Shiratori - CEX
Masahiro Ikeda - OTH
Katsuhiko Yoshida - OTH
Naoya Unno - OTH
Shigeki Tamura - EDR
Kenichi Nishimura - SMD
Who are the major shareholders of AFC-HD AMS Life Science Co?

Here are the top five shareholders of AFC-HD AMS Life Science Co based on the size of their shareholding:

Asayama (Tadahiko) Individual Investor
Percentage owned: 15.2% (2.15m shares)
Asayama (Takehiko) Individual Investor
Percentage owned: 7.86% (1.11m shares)
Asayama (Maiko) Individual Investor
Percentage owned: 2.36% (334k shares)
Asayama (Marina) Individual Investor
Percentage owned: 2.33% (330k shares)
AFC-HD AMS Life Science Co., Ltd. Customers Corporation
Percentage owned: 1.97% (279k shares)
Similar to 2927
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.